Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis

Peer Review reports

Original Submission
18 Jul 2015	Submitted	Original manuscript
8 Sep 2015	Author responded	Author comments - Xueqin Yang
Resubmission - Version 2
8 Sep 2015	Submitted	Manuscript version 2
11 Sep 2015	Reviewed	Reviewer Report - Zhanwei Wang
14 Sep 2015	Reviewed	Reviewer Report - Roberto Passera
24 Sep 2015	Reviewed	Reviewer Report - Tobias R. Overbeck
11 Oct 2015	Author responded	Author comments - Xueqin Yang
Resubmission - Version 3
11 Oct 2015	Submitted	Manuscript version 3
25 Nov 2015	Author responded	Author comments - Xueqin Yang
Resubmission - Version 4
25 Nov 2015	Submitted	Manuscript version 4
Publishing
5 Dec 2015	Editorially accepted
16 Dec 2015	Article published	10.1186/s12885-015-1978-2

Back to article page